# Trial of Verapamil in Chronic Rhinosinusitis

> **NCT02454608** · NA · TERMINATED · sponsor: **Benjamin Bleier** · enrollment: 29 (actual)

## Conditions studied

- Sinusitis
- Nasal Polyps

## Interventions

- **DRUG:** Verapamil HCl
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02454608
- **Lead sponsor:** Benjamin Bleier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-05
- **Primary completion:** 2016-03
- **Final completion:** 2017-05
- **Target enrollment:** 29 (ACTUAL)
- **Why stopped:** Evidence that the dose is insufficient.
- **Last updated:** 2018-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02454608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02454608, "Trial of Verapamil in Chronic Rhinosinusitis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02454608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*